GSK presents scientific advances to improve patient outcomes at the ...

GSK will present 14 abstracts at the American Association for the Study of Liver Diseases' (AASLD) The Liver Meeting 2023, taking place in Boston, MA from 10- ...

Press release archive | GSK

GSK presents scientific advances to improve patient outcomes at the American Association for the Study of Liver Diseases' The Liver Meeting® 2023. New data ...

GSK announces positive phase III results from ANCHOR trials for ...

GSK continues to build on decades of pioneering work to deliver more ambitious treatment goals, develop the next generation standard of care, ...

GSK to demonstrate its commitment to improving outcomes for ...

GlaxoSmithKline (GSK) plc will present new findings in support of advancing treatment for certain gynaecologic cancers, including data ...

GSK to showcase significant scientific advances in renal care at the ...

Additionally, GSK will present data on BENLYSTA for the treatment of lupus nephritis, including healthcare resource utilisation and cost ...

GSK to highlight the latest advances in cancer research from across ...

GSK will present new findings from across its diverse oncology portfolio and pipeline at the congress.

New data at ASCO showcases the transformational potential of ...

The presentations support GSK's ongoing focus and commitment to advance care in blood cancers, gynecologic cancers and certain solid tumors ...

GSK and ViiV Healthcare to present scientific advancements in their ...

We look forward to connecting with the scientific community to determine how we can continue to develop innovative solutions to prevent and ...

GSK Grants and Corporate Funding

GSK provides financial support to organizations that: · Foster an increased understanding of scientific, clinical, healthcare, and community issues · Have a ...

GSK - Facebook

Learn more about this survey and our new Your Cancer Is Our Challenge initiative that is raising awareness of barriers to care and inspiring solutions to ...

GSK at American Society of Hematology 2023

GSK will present its latest research advancements in blood cancers at the American Society of Hematology (ASH) 2023 Annual Meeting and Exposition.

Technology as a Tool for Improving Patient Safety | PSNet

In the past several decades, technological advances have opened new possibilities for improving patient safety. Using technology to digitize ...

GSK on LinkedIn: 'Patients can breathe easier today'

Scientific advances in asthma and COPD care could prevent irreversible lung damage. ... improve patient outcomes, and potentially allow for ...

Global patient safety report 2024 lob p - IRIS Home

In 2023, World Patient Safety Day emphasized the critical role of patients and families in shaping health care. ... advances have marked the patient safety ...

AI/ML and experimental frameworks for precision oncology at GSK

It now presents a wide range of opportunities to optimize clinical development at GSK by improving the translatability of in vitro models, discovery of ...

CU Anschutz and GSK Join Forces to Advance Immunotherapies for ...

Richard Schulick and Yuwen Zhu have identified a series of novel checkpoint inhibitors and are now partnering with GSK (GlaxoSmithKline), a ...

GSK Presents Optimistic CKD-Related Anemia Results Months After ...

GlaxoSmithKline is lining up a potential new treatment for patients ... GSK's Chief Scientific Officer and President of Research and Development ...

GSK enters agreement to acquire CMG1A46 from Chimagen ...

GSK plans to develop and commercialise CMG1A46 with a focus on B cell-driven autoimmune diseases, such as systemic lupus erythematosus (SLE) and ...

GSK steps up to support new FDI project on partially dentate patients

We are so pleased that GSK has offered their full backing to improve health outcomes for partially dentate patients. It is essential to consider the specific ...

GSK IMPACT Awards | Triangle Community Foundation

The more we understand the connection between our health and our community, the more we can improve it. GSK is a global biopharma leader with new ambitions and ...